Yong Xia

ORCID: 0000-0001-5319-5858 · 2 papers in corpus
2026
·doi:10.1016/j.ygyno.2026.01.697
lab-animal 2019
Scientific reports ·doi:10.1038/s41598-019-38778-2

Metformin, an inexpensive, well-tolerated oral agent that is a commonly used first-line treatment for type 2 diabetes, has become the focus of intense research as a potential anticancer agent. In this study, we describe the inhibitory effec…